pharmaceutical manufacturing
Steriline will unveil its new RVFCM11-S filling machine at this year's Pharmintech in Milan at the end of May 2025. The system is specifically designed for pharmaceutical companies involved in cell and gene therapy. It meets the current regulatory requirements of Annex 1 of the EU GMP guidelines. The RVFCM11-S combines robot technology, magnetic levitation technology, and a double-walled...
Fette Compacting and CDMO "CMIC CMO USA" are entering into a strategic partnership. The collaboration is an important step in the implementation of Fette Compacting's new strategy, “Together - from lab to production.” It strengthens the company's position as a comprehensive process partner. The focus of the collaboration is the integration of the FE CPS continuous direct compression system with an...
Roche plans to invest $50 billion in the US over the next five years. These investments will strengthen the pharmaceutical company's presence in the United States, where it has 13 manufacturing sites and 15 research and development sites for pharmaceuticals and diagnostics. More than 12,000 new jobs are expected to be created, including nearly 6,500 in construction and 1,000 in new and expanded...
Bürkert Fluid Control Systems has joined Green Elephant Biotech as a strategic investor. Together, the MSR manufacturer and the Germany-based start-up want to develop more efficient, more flexible and more sustainable cell cultivation processes for the pharmaceutical and biotech industry. The partnership is intended to enable more cost-effective production of therapeutics and facilitate access to...
Dechema, the organiser of Achema, and Gulf Energy Information will jointly host the ‘ChemE Show’ - Powered by Achema in Houston, Texas, for the first time in 2026. The new annual event is aimed at experts, decision-makers and solution providers along the entire value chain of chemical and bio-based production. The ‘ChemE Show’ will focus on North America's dynamic chemical and pharmaceutical...
Touchlight, a Contract Development and Manufacturing Organisation (CDMO), has announced that its Hampton, UK facility has achieved GMP certification. This makes Touchlight the first synthetic DNA manufacturer in the world to receive regulatory approval for the manufacture of Active Pharmaceutical Ingredient (API). This places the company in a unique position to support its growing customer base in...
Vetter, a global pharmaceutical service provider, is expanding its management team. From January 2025, Thomas Otto and Peter Sölkner will join Henryk Badack, Titus Ottinger and Carsten Press in managing the family-owned company. By expanding its management team, the independent CDMO for the manufacturing of complex injectable drugs is ensuring its sustainable growth. “We at Vetter are committed to...
Goldfuß Engineering has developed a new system in which a hygienic “Motoman HD7” handling robot from Yaskawa fills up to 120 vials per hour under cleanroom conditions. Clinical studies or personalized medicine usually require small batches of medication, for example injection solutions, which are filled into vials. These vials or glass containers must be sterile and aseptic. The small batch sizes...
Vetter is investing in the expansion of its production capacities in Germany and the USA. The pharmaceutical service provider will relocate its site for development services within the USA and continue to expand there. At the same time, in addition to the ongoing capacity expansions in Ravensburg and Langenargen, Vetter is planning to establish a further site in Saarlouis, Saarland, for the...
With a new investment commitment of $5.3 billion, Eli Lilly plans to more than double its investment in the Lebanon production site in the US state of Indiana. This expansion is intended to significantly increase production capacity for active pharmaceutical ingredients (API) for two drugs currently in high demand for the treatment of obesity and type 2 diabetes. At a total of nine billion dollars...
